Pharmaceutical Care Management Association (PCMA)

Registered Principal Details

Business Or Interest:
Pharmacy Benefits Management

Lobbying Interests:
Primarily pharmacy benefits management, including health care, insurance, pharmaceuticals and state budget matters as they relate to PBMs

CEO Name:
JC Scott

Contact
HC
Heather Cascone
325 7th Street NW, 9th Fl
Washington, DC 20004
(202) 744-8416
hcascone@pcmanet.org
http://www.pcmanet.org

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 7
Assembly Bill 7
Relating to: pharmacy benefit managers, prescription drug benefits, and granting rule-making authority. (FE)

Bill Text and History

Other
Notification Date
8/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
Comments as to effective date of the bill only
Assembly Bill 184
Assembly Bill 184
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.

Bill Text and History

Against
Notification Date
2/7/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 718
Assembly Bill 718
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.

Bill Text and History

Against
Notification Date
2/7/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 745
Assembly Bill 745
Relating to: prohibiting step therapy protocols for certain cancer drugs.

Bill Text and History

Against
Notification Date
2/7/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 753
Senate Bill 753
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.

Bill Text and History

Against
Notification Date
1/19/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2021
January - June
2021
July - December
2022
January - June
Total
Total Lobbying Expenditures 2021
January - June
$108.17
2021
July - December
$1,406.21
2022
January - June
$39,598.00
Total $41,112.38
Total Hours Communicating 2021
January - June
1.00
2021
July - December
0.00
2022
January - June
1.50
Total 2.50
Total Hours Other 2021
January - June
0.00
2021
July - December
13.00
2022
January - June
22.50
Total 35.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: pharmacy benefit managers, prescription drug benefits, and granting rule-making authority. (FE)
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
100 %
2021
July - December
2022
January - June
2022
July - December
Total 3 %
Relating to: prohibiting step therapy protocols for certain cancer drugs.
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
5 %
2022
July - December
Total 3 %
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
10 %
2022
July - December
Total 5 %
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
40 %
2022
July - December
Total 26 %
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
45 %
2022
July - December
Total 29 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

No topics found.

Minor Efforts

No minor efforts found.

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
100 %
2022
January - June
2022
July - December
Total 34 %

Filed Statements of Lobbying Activity and Expenditures